Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Oral antiviral treatments for COVID-19: opportunities and challenges | SpringerLink
A global treatments for coronaviruses including COVID‐19 - Yousefi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Structural biology of SARS-CoV-2: open the door for novel therapies | Signal Transduction and Targeted Therapy
Infectious diseases | Nature Reviews Drug Discovery
SARS-CoV-2 antivirals ~ ViralZone
JKMS :: Journal of Korean Medical Science
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Drug repurposing approach to fight COVID-19 | SpringerLink
Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Life | Free Full-Text | Statins in COVID-19 Therapy
Review of pharmacologic and immunologic agents in the management of COVID-19 | Biosafety and Health
Frontiers | Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
